Pappot H - Search Results

1

Late effects - the new focus of follow-up.

Johansen C, von Heymann A, Rafn BS, Borgquist S, Christiansen P, Christensen P, Zachariae R, Pappot H, Lassen U. Johansen C, et al. Among authors: pappot h. Acta Oncol. 2022 Oct;61(10):1163-1164. doi: 10.1080/0284186X.2022.2137845. Epub 2022 Oct 28. Acta Oncol. 2022. PMID: 36306149 No abstract available.

2

Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.

Skov BG, Fischer BM, Pappot H. Skov BG, et al. Among authors: pappot h. Lung Cancer. 2008 Jan;59(1):88-94. doi: 10.1016/j.lungcan.2007.07.025. Epub 2007 Oct 1. Lung Cancer. 2008. PMID: 17905466

3

Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study.

Quist M, Rørth M, Langer S, Jones LW, Laursen JH, Pappot H, Christensen KB, Adamsen L. Quist M, et al. Among authors: pappot h. Lung Cancer. 2012 Feb;75(2):203-8. doi: 10.1016/j.lungcan.2011.07.006. Epub 2011 Aug 3. Lung Cancer. 2012. PMID: 21816503

4

Erratum: Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis.

Holmsten K, Dohn L, Jensen NV, Shah CH, Jäderling F, Pappot H, Ullén A. Holmsten K, et al. Among authors: pappot h. Oncol Lett. 2017 Jun;13(6):5035. doi: 10.3892/ol.2017.6082. Epub 2017 Apr 24. Oncol Lett. 2017. PMID: 28588741 Free PMC article.

5

The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial.

Tolstrup LK, Bastholt L, Dieperink KB, Möller S, Zwisler AD, Pappot H. Tolstrup LK, et al. Among authors: pappot h. J Patient Rep Outcomes. 2020 Oct 30;4(1):88. doi: 10.1186/s41687-020-00255-0. J Patient Rep Outcomes. 2020. PMID: 33125537 Free PMC article.

6

[Lung cancer--a technological challenge II. New approaches to treatment].

Pappot H, Fischer BM, Almasi CE, Skuladottir H, Nøttrup TJ. Pappot H, et al. Ugeskr Laeger. 2004 Nov 15;166(47):4243-5. Ugeskr Laeger. 2004. PMID: 15587353 Danish. No abstract available.

7

Presence of urokinase plasminogen activator, its inhibitor and receptor in small cell lung cancer and non-small cell lung cancer.

Pappot H, Pfeiffer P, Grondahlhansen J, Skov B. Pappot H, et al. Int J Oncol. 1997 Jan;10(1):177-82. doi: 10.3892/ijo.10.1.177. Int J Oncol. 1997. PMID: 21533361

8

[Lung cancer--a technological challenge I. Diagnostics and staging].

Nøttrup TJ, Fischer BM, Almasi CE, Skuladottir H, Pappot H. Nøttrup TJ, et al. Among authors: pappot h. Ugeskr Laeger. 2004 Nov 15;166(47):4241-3. Ugeskr Laeger. 2004. PMID: 15587352 Danish. No abstract available.

9

ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts.

de Witte H, Pappot H, Brünner N, Grøndahl-Hansen J, Hoyer-Hansen G, Behrendt N, Guldhammer-Skov B, Sweep F, Benraad T, Danø K. de Witte H, et al. Among authors: pappot h. Int J Cancer. 1997 Jul 29;72(3):416-23. doi: 10.1002/(sici)1097-0215(19970729)72:3<416::aid-ijc8>3.0.co;2-s. Int J Cancer. 1997. PMID: 9247284 Free article.

10

[Combination chemotherapy for treatment of metastasing non-small-cell lung carcinoma. Monotherapy of combinations of two or three agents--a survey of a Cochrane review].

Mellemgaard A, Pappot H. Mellemgaard A, et al. Among authors: pappot h. Ugeskr Laeger. 2009 Jun 15;171(25):2084-7. Ugeskr Laeger. 2009. PMID: 19671386 Review. Danish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters